中国现代药物应用
中國現代藥物應用
중국현대약물응용
Chinese Journal of Modern Drug Application
2015年
19期
25-26
,共2页
张波%姜兴金%魏伟%杨明洲%王霞
張波%薑興金%魏偉%楊明洲%王霞
장파%강흥금%위위%양명주%왕하
腺性膀胱炎%经尿道电切%黏膜下注射
腺性膀胱炎%經尿道電切%黏膜下註射
선성방광염%경뇨도전절%점막하주사
Glandular cystitis%Transurethral electronresection%Submucous injection
目的:探讨对腺性膀胱炎使用尿道电切加黏膜下注射丝裂霉素的临床效果。方法80例腺性膀胱炎患者,随机分为试验组与对照组,各40例。试验组采取尿道电切加黏膜下注射丝裂霉素治疗,对照组采取尿道电切加膀胱灌注丝裂霉素治疗。观察两组患者治愈率以及不良反应率。结果试验组治愈率高于对照组,差异有统计学意义(P<0.05);试验组不良反应率低于对照组,差异有统计学意义(P<0.05)。结论对腺性膀胱炎使用尿道电切加黏膜下注射丝裂霉素的治疗方法可有效提高治愈率,降低不良反应发生率,值得在临床推广。
目的:探討對腺性膀胱炎使用尿道電切加黏膜下註射絲裂黴素的臨床效果。方法80例腺性膀胱炎患者,隨機分為試驗組與對照組,各40例。試驗組採取尿道電切加黏膜下註射絲裂黴素治療,對照組採取尿道電切加膀胱灌註絲裂黴素治療。觀察兩組患者治愈率以及不良反應率。結果試驗組治愈率高于對照組,差異有統計學意義(P<0.05);試驗組不良反應率低于對照組,差異有統計學意義(P<0.05)。結論對腺性膀胱炎使用尿道電切加黏膜下註射絲裂黴素的治療方法可有效提高治愈率,降低不良反應髮生率,值得在臨床推廣。
목적:탐토대선성방광염사용뇨도전절가점막하주사사렬매소적림상효과。방법80례선성방광염환자,수궤분위시험조여대조조,각40례。시험조채취뇨도전절가점막하주사사렬매소치료,대조조채취뇨도전절가방광관주사렬매소치료。관찰량조환자치유솔이급불량반응솔。결과시험조치유솔고우대조조,차이유통계학의의(P<0.05);시험조불량반응솔저우대조조,차이유통계학의의(P<0.05)。결론대선성방광염사용뇨도전절가점막하주사사렬매소적치료방법가유효제고치유솔,강저불량반응발생솔,치득재림상추엄。
ObjectiveTo investigate clinical effect by transurethral electronresection combined with submucous injection of mitomycin for glandular cystitis.MethodsA total of 80 glandular cystitis patients were randomly divided into experimental group and control group, with 40 cases in each group. The experimental group received transurethral electronresection combined with submucous injection of mitomycin for treatment, and the control group received transurethral electronresection combined with bladder irrigation of mitomycin for treatment. Cure rate and incidence of adverse reactions in the two groups were observed.ResultsThe experimental group had higher cure rate than the control group, and their difference had statistical significance (P<0.05). The experimental group had lower incidence of adverse reactions than the control group, and their difference had statistical significance (P<0.05).ConclusionImplement of transurethral electronresection combined with submucous injection of mitomycin for glandular cystitis can effectively improve cure rate and reduce incidence of adverse reactions. It is worthy of clinical promotion.